Meiji Seika, SII tie up to bring Japanese Encephalitis vaccine to India; Medreich eyes expansion TOKYO: Meiji Seika Pharma-owned Medreich Pharma is eyeing inorganic growth and more generics supply from India, while the parent has tied up with Serum Institute of India (SII) to launch Japanese Encephalitis vaccine in the country.“SII will take the required...